oxford astrazeneca

AstraZeneca Vaccine 92% effective against Delta variant

AstraZeneca Vaccine 92% effective against Delta variant

AstraZeneca said new data from Public Health England (PHE) demonstrated COVID-19 Vaccine AstraZeneca, offers high levels of protection against the Delta variant. AstraZeneca vaccine is used in India as Covishield. Real-world data from PHE, demonstrated two doses of COVID-19 Vaccine AstraZeneca are 92% effective against hospitalization due to the Delta variant and showed no deaths among those vaccinated. The higher efficacy against severe disease and hospitalization is supported by recent data showing a strong T-cell response to COVID-19 Vaccine AstraZeneca, which should correlate with high and durable protection. Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, said: “This real-world evidence shows…
Read More
26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt

26 cases of blood clotting, bleeding due to AstraZeneca vaccine in India: Govt

The government on Monday said it identified 26 potential cases of bleeding and blood clotting in India due to the administration of the AstraZeneca vaccine in India.Serum Institute of India is producing Covishield vaccine in India in partnership with AstraZeneca. The Union Health Ministry said in a statement on Monday that over 23,000 adverse events have been reported since the vaccination drive involving Covishield and Covaxin vaccines started in the country and of these 700 cases were reported to be serious. The ministry is separately issuing advisories to healthcare workers and vaccine beneficiaries to encourage people to be aware of…
Read More